The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease (Q46628501)
scientific article published in April 2008
Language:
(P31) (Q13442814)
(P50) (Q38544252)
(Q59688400)
(Q99628358)
(Q138588608)
(Q85589262)
(P304) 4311-4316
(P407) (Q1860)
(P433) 17
(P478) 28
(P577) Tuesday, April 1, 2008
(P921) (Q11085)
(P1433) (Q1709864)
(P1476) "The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease" (language: en)
(P2093) Stefan Schuster
Jun Tang Guo
(P2860) (Q28377680)
(Q34035684)
(Q32061819)
(Q34325365)
(Q43715960)
(Q48424865)
(Q44037073)
(Q31091605)
(Q44214541)
(Q35085979)
(Q44383212)
(Q28585945)
(Q46986296)
(Q48548811)
(Q30594829)
(Q26778491)
(Q42447908)
(Q42539090)
other details
description scientific article published in April 2008

External Links